Doctor’s Passport

Find your next topic

Explore the current textbook

Available drafts · Clinical review pending
Membership
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
Rapid

Margins and re-excision

Essential points for quick revision.

Saved on this device

Synopsis

Interpret radial margin reports by invasive and in-situ pathology, apply current NICE thresholds, and make re-excision decisions that balance local control, radiotherapy and breast preservation.

  • A margin is the relationship between tumour and the inked specimen surface, not the surgeon’s visual impression of the cavity. Orientation lets pathology identify the involved direction.
  • After breast-conserving surgery, NICE says offer further surgery when invasive cancer or DCIS is on ink at a radial margin, meaning 0 mm.
  • For invasive cancer with or without DCIS, consider further surgery when tumour is more than 0 mm but less than 1 mm from a radial margin.

Investigation priorities

01
Oriented specimen histopathologyFirst step

Measure invasive and DCIS distances to each inked radial surface and identify tumour at ink.

Management branches

Worked case: involved marginTurn a 0 mm result into a directed plan

After conservation for a 19 mm invasive cancer, pathology reports invasive tumour on the medial radial ink and the specimen is clearly orientated.

  1. In this illustrative case, the pathologist confirms that the medial radial surface contains invasive tumour at ink, not merely a close margin. There is no separately submitted clear cavity shave that would change the final margin. The oriented specimen and preoperative images localise the residual concern to the medial cavity.
  2. The surgeon explains that NICE recommends offering further surgery for invasive cancer or DCIS at a 0 mm radial margin, so this invasive on-ink result requires that offer. Imaging shows a focal remaining concern and adequate breast tissue for another directed excision. The patient compares re-excision with completion mastectomy, including cosmetic cost, possible further surgery and the adjuvant-treatment plan, and chooses medial re-excision.
Open full textbook Answer 2 questions
Sources and review status3 sources · checked 8 Sept 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Apply principles in context and verify current guidance when a decision affects care. Source check completed 8 Sept 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom